Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

New Invited Women to Breast Cancer Screening: a Multi-centre, Longitudinal, Controlled, Randomised Study on a Decision-aid to Support Informed Choice

NCT03097653 is registered in ClinicalTrials.gov with Mario Negri Institute for Pharmacological Research as lead sponsor.

NCT NCT03097653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03097653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
New Invited Women to Breast Cancer Screening: a Multi-centre, Longitudinal, Controlled, Randomised Study on a Decision-aid to Support Informed Choice
Lead sponsor
Mario Negri Institute for Pharmacological Research
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2017
Completion date
April 30, 2019
Enrollment
1,001 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer